This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
PTC Therapeutics goes public on second try with $134mm IPO
02 Jul 2013
Just over three months after completing a $60mm Series G financing, PTC Therapeutics Inc. (focused on orphan and ultra-orphan diseases) has netted $134mm through its initial public offering of 9.6mm common shares (including the overallotment) at $15. Just days ago the company said it intended to sell 6.9mm shares between $13-16. This was PTC's second try after withdrawing an S-1 filing in 2007 because it already had sufficient funding through grants and licensing deals.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?